Life Stressors Could Contribute to Multiple Sclerosis Flares, Disability
Researchers discovered that stressful events in childhood and adulthood contributed significantly to participants’ level of disability and multiple sclerosis flares.
Category: Multiple Sclerosis
Multiple Sclerosis
Latest
Multiple Sclerosis
Latest
This Tool Investigates Rare Cells That Could Play a Key Role in Multiple Sclerosis
FIND-seq combines nucleic acid cytometry, microfluidics, and droplet sorting to isolate and analyze cells of interest in multiple sclerosis.
Multiple Sclerosis
Latest
Helius Medical Technologies Adds Third Center of Excellence
Helius Medical Technologies Inc announces the addition of Oregon Health & Science University to its Therapeutic Experience Program.
Aerobic Exercise Training Promising for Restoring Function in Individuals with Multiple Sclerosis-Related Thalamic Atrophy
Thalamic atrophy needs to be considered in clinical studies of the functional abilities of individuals with multiple sclerosis, per research.
Read More
Kessler Foundation Receives Grant to Support Postdoctoral Training Program for Rehabilitative Research in Multiple Sclerosis
National Multiple Sclerosis Society awards grant to Kessler Foundation’s John DeLuca, PhD, to continue multiple sclerosis curriculum.
Read More
Accelerated Cure Project Collaboration Evaluates COVID-19 Vaccine Efficacy in MS Patients
Accelerated Cure Project and others are collaborating to study immune response to COVID-19 vaccinations of people living with MS.
Read More
Health Care Spending May Help Explain Link Between MS and Latitude
A new analysis shows that the amount a country spends on health care may help explain the link between MS and latitude.
Read More
MSAA Launches Ultimate MS Treatment Guide
The Multiple Sclerosis Association of America launches the Ultimate MS Treatment Guide to help people with MS learn about therapies.
Read More
Helius Medical Technologies Inc Reports Second Quarter 2022 Financial Results
Helius Medical Technologies Inc, a neurotech company, reports financial results for the quarter that ended June 30, 2022.
Read More
Researchers Discover New Prognostic Marker for Multiple Sclerosis Severity
A MedUni Vienna study suggests that the retina can be used as a prognostic marker to predicts the severity of future MS relapses.
Read More
Quality of Life with Multiple Sclerosis May Depend on Several Factors
For people with multiple sclerosis, there are specific factors that may affect a person’s physical and mental quality of life.
Read More
MS Patients Had Strong T-Cell Activation in Response to COVID-19 Vaccination
Multiple sclerosis patients receiving anti-CD20 therapy saw strong T-cell activation after receiving two doses of the COVID-19 vaccine.
Read More
Mymee Acquires Breakthrough Health, a Digital Health Platform for MS
Mymee has acquired Berlin-based Breakthrough Health, the creator of the mobile app Emilyn for people with multiple sclerosis (MS).
Read More
AHN Specialists Studying New Treatment for Relapsing Multiple Sclerosis
Via the FENhance study, AHN doctors are exploring the use of a new drug to treat relapsing or primary progressive multiple sclerosis.
Read More
Scientists Advocate for Further Research on Benefits of Exercise Training for Managing Multiple Sclerosis
Experts encourage ongoing investigation of the benefits of exercise for people with multiple sclerosis, citing shortcomings of other studies.
Read More
Rune Labs Study to ID Biomarkers of Multiple Sclerosis Lesions
Rune Labs is enrolling patients with multiple sclerosis in a study to identify neurophysiological biomarkers of the disease.
Read More
Helius Medical Technologies Inc Announces Online Training for PoNS Therapy
PoNS Therapy training for physical therapists treating patients with multiple sclerosis is now available on demand from Helius.
Read More
Virtual Reality Technology Could Strengthen Effects of Traditional Rehabilitation for Multiple Sclerosis
Virtual reality may increase the effectiveness of cognitive rehabilitation and exercise training in individuals with MS, per Kessler.
Read More